ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative, as he shares ...

ONCOLife presents an exclusive interview with Lorna Warwick, CEO of Lymphoma Coalition. In this session, we explore the critical role of patient advocacy in improving access to CAR T-cell therapy — a ...

About ONCOLife ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

ONCOLife presents an exclusive interview with Nick Slack, Chairman and CEO of The START Center for Cancer Research. In this session, we explore how the integration of the Carolina Urologic Research ...

Oncolytic viruses are emerging as a promising development in cancer treatment, not only destroying cancer cells but also modulating the tumor microenvironment to enhance immune responses. We had an ...

The first AI-powered companion diagnostic for non-small cell lung cancer (NSCLC) has received FDA Breakthrough Device Designation. Developed by Roche, Ventana TROP2 RxDx Device combines ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

Durvalumab, a PD-L1 immune checkpoint inhibitor, works by blocking the interaction between PD-L1 and immune-inhibitory proteins PD-1 and CD80, thereby lifting the brakes on the immune system’s ...

Adcentrx Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its novel antibody-drug conjugate (ADC), ADRX-0706 for advanced cervical ...